This study assessed the impact of hyperpolypharmacy on hospital readmission risk in 2 Medicare populations and identified ...
Pharmaceutical manufacturers offer robust patient services programs – with nurse navigators, mobile apps, in-home testing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results